M. Maurer

发表

Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress.

S. Wagner, B. Garg, G. Pathria, 2016, Mutagenesis.

Reconstitution of human MCF‐7 breast cancer cells with caspase‐3 does not sensitize them to action of CDK inhibitors

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular biochemistry.

Comprehensive comparative and semiquantitative proteome of a very low number of native and matched epstein-barr-virus-transformed B lymphocytes infiltrating human melanoma.

K. Bennett, S. Wagner, J. Colinge, 2014, Journal of proteome research.

Roscovitine Differentially Affects Asynchronously Growing and Synchronized Human MCF‐7 Breast Cancer Cells

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2009, Annals of the New York Academy of Sciences.

Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment

J. Węsierska‐Gądek, E. Walzi, O. Komina, 2009, Journal of cellular biochemistry.

Natural Compounds as Specific Inhibitors of Cyclin-Dependent Kinases – Past, Present and Future

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2012 .

Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine

J. Węsierska‐Gądek, M. Maurer, Tanja Schreiner, 2007, Cellular & Molecular Biology Letters.

Whether to target single or multiple CDKs for therapy? That is the question

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular physiology.

Interference with ER‐α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER‐positive breast cancer cells

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular biochemistry.

Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.

K. Mertz, S. Wagner, I. Wolf, 2016, Human pathology.

Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence

J. Węsierska‐Gądek, G. Schmid, M. Kramer, 2007, Journal of cellular biochemistry.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

Johannes Griss, Zhi Wei, Jie Zhang, 2017, Nature Communications.

Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER.

J. Węsierska‐Gądek, M. Maurer, N. Zulehner, 2011, Journal of experimental therapeutics & oncology.

Roscovitine, a small molecule CDK inhibitor induces apoptosis in multidrug-resistant human multiple myeloma cells.

J. Węsierska‐Gądek, M. Maurer, O. Komina, 2011, Journal of experimental therapeutics & oncology.

Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2009, Acta biochimica Polonica.

Inhibition of farnesyl protein transferase sensitizes human MCF‐7 breast cancer cells to roscovitine‐mediated cell cycle arrest

J. Węsierska‐Gądek, G. Schmid, M. Maurer, 2007, Journal of cellular biochemistry.

Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.

J. Węsierska‐Gądek, M. Kramer, M. Maurer, 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

A slow-cycling subpopulation of melanoma cells with highly invasive properties

Sydney M. Shaffer, K. Bennett, A. Raj, 2017, Oncogene.

Combining filter-aided sample preparation and pseudoshotgun technology to profile the proteome of a low number of early passage human melanoma cells.

K. Bennett, S. Wagner, A. Müller, 2013, Journal of proteome research.

Interference with Estrogen Receptor-α by Dietary Components: Impact on the Balance Between Cell Proliferation and Cell Death

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2012 .

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen‐induced phosphorylation of ER‐α in human ER‐positive breast cancer cells

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular biochemistry.

PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells☆

J. Węsierska‐Gądek, O. Komina, A. Składanowski, 2012, Biochemical pharmacology.

Promotion of apoptosis in cancer cells by selective purine-derived pharmacological CDK inhibitors: one outcome, many mechanisms.

J. Węsierska‐Gądek, M. Maurer, 2011, Current pharmaceutical design.